{"disease":{"id":"allergy-to-peg-e-coli-asparaginase","name":"allergy to peg e coli asparaginase"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT00928200","title":"Erwinase for Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) (IND 104224)","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":1,"lead_sponsor_name":"Therapeutic Advances in Childhood Leukemia Consortium","has_results":true}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}